Nanjing Medical Commission filed investigation

The Nanjing Medical Bulletin, which entered troubled times, said the company had received a notice of investigation issued by the SFC. On suspicion of failing to disclose information according to regulations, the SFC filed an investigation. September 7, President He Jinxian resigned for personal reasons, this is the former chairman Zhou Yaoping after his departure in March, the third left the Nanjing medical executives. In April this year, Ding, the original director and executive vice president of Nanjing Medicine, resigned for personal reasons. September 16, Nanjing Pharmaceutical appeared on the bulk trading platform, a shareholder reduction of 5 million shares, set now 24.4 million yuan. and observation of its main shareholders, holding the number of shares in more than 5 million shares, including major shareholders in only 5 institutions, respectively, Nanjing Pharmaceutical Group, China Dividend Mixed open-end Fund, Xinyu Lee Investment Management Center, Warburg Trust Limited liability company, Nanjing Zijin Investment Group. In addition to the resignation of senior executives, the main shareholders to reduce stocks, Nanjing medicine since 2011 to avoid being St has been selling assets. 2012, the company has sold property profits of 92.05 million yuan, to achieve a net profit of 10.82 million yuan, so as to avoid the fate of St. Since 2013, Nanjing Medicine has continued to transfer or sell up to 12 shares of holding and equity companies. Relying on the sale of assets to bring 50.87 million yuan non-recurrent income, the first half of this year, Nanjing medicine to achieve a net profit of 16.43 million yuan, but the actual loss after deducting the non-recurrent profit and loss of 14.88 million yuan.